Government Investment Pays Off: Cue Health Gets EUA For At-Home OTC COVID-19 Test
Executive Summary
After the US government invested almost half a billion dollars to ensure Cue Health could scale up production, the FDA announced the self-administered test will now be available over the counter.
You may also be interested in...
US FDA Recommendations On Developing Serial COVID-19 Tests Could Accelerate OTC Approval
FDA published a supplemental template for molecular and antigen COVID-19 EUA sponsors with products to be used for serial testing, and a fact sheet that screening program organizers can use to pick the right test.
FDA Takes Steps To Help Serial Testing Efforts, Track Asymptomatic COVID-19 Cases
The agency published a supplemental template for molecular and antigen COVID-19 EUA sponsors whose product can be used for serial testing, and a fact sheet that screening program organizers can use to pick the right test.
Biden Admin Pays Ellume $231M To Build COVID-19 US Test Plant
The government seems to be betting the company’s over-the-counter at-home antigen diagnostic test will be a game changer in stopping the spread of the coronavirus.